193 related articles for article (PubMed ID: 31501568)
1. Targeting for delivery.
Nat Biomed Eng; 2019 Sep; 3(9):671-672. PubMed ID: 31501568
[No Abstract] [Full Text] [Related]
2. Nanoparticle approaches to combating drug resistance.
Moon JH; Moxley JW; Zhang P; Cui H
Future Med Chem; 2015 Aug; 7(12):1503-10. PubMed ID: 26334205
[TBL] [Abstract][Full Text] [Related]
3. Nanomedicine: the promise and challenges in cancer chemotherapy.
Naguib YW; Cui Z
Adv Exp Med Biol; 2014; 811():207-33. PubMed ID: 24683034
[No Abstract] [Full Text] [Related]
4. Anticancer drug delivery with nanoparticles.
Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U
In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748
[TBL] [Abstract][Full Text] [Related]
5. Nanoscale drug delivery for targeted chemotherapy.
Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine for multimodality treatment of cancer.
Mi Y; Guo Y; Feng SS
Nanomedicine (Lond); 2012 Dec; 7(12):1791-4. PubMed ID: 23249329
[No Abstract] [Full Text] [Related]
7. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine and drug delivery.
Wei C; Wei W; Morris M; Kondo E; Gorbounov M; Tomalia DA
Med Clin North Am; 2007 Sep; 91(5):863-70. PubMed ID: 17826106
[TBL] [Abstract][Full Text] [Related]
9. New strategies in melanoma therapy: can nanoparticles overcome chemoresistance?
Badea I
Nanomedicine (Lond); 2017 Jul; 12(14):1623-1626. PubMed ID: 28635551
[No Abstract] [Full Text] [Related]
10. Advances in refunctionalization of erythrocyte-based nanomedicine for enhancing cancer-targeted drug delivery.
Sun D; Chen J; Wang Y; Ji H; Peng R; Jin L; Wu W
Theranostics; 2019; 9(23):6885-6900. PubMed ID: 31660075
[TBL] [Abstract][Full Text] [Related]
11. Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.
Ruttala HB; Ramasamy T; Madeshwaran T; Hiep TT; Kandasamy U; Oh KT; Choi HG; Yong CS; Kim JO
Arch Pharm Res; 2018 Feb; 41(2):111-129. PubMed ID: 29214601
[TBL] [Abstract][Full Text] [Related]
12. Novel Nanoparticles for Tumor Targeting Drug Delivery.
Gao H
Curr Drug Metab; 2018; 19(9):722. PubMed ID: 30187836
[No Abstract] [Full Text] [Related]
13. Nanotheraputics.
Ravi Kumar MN; Blanco-Prieto MJ; Waterhouse DN
Cancer Lett; 2013 Jul; 334(2):155-6. PubMed ID: 23523611
[No Abstract] [Full Text] [Related]
14. Programmable nanomedicine: synergistic and sequential drug delivery systems.
Pacardo DB; Ligler FS; Gu Z
Nanoscale; 2015 Feb; 7(8):3381-91. PubMed ID: 25631684
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.
Pridgen EM; Langer R; Farokhzad OC
Nanomedicine (Lond); 2007 Oct; 2(5):669-80. PubMed ID: 17976029
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicine in cancer treatment.
Yih TC; Wei C
Nanomedicine; 2005 Jun; 1(2):191-2. PubMed ID: 17292078
[No Abstract] [Full Text] [Related]
17. New Strategies in Cancer Nanomedicine.
Tong R; Kohane DS
Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
[TBL] [Abstract][Full Text] [Related]
18. Peptide chemistry encounters nanomedicine: recent applications and upcoming scenarios in cancer.
Falanga A; Galdiero S
Future Med Chem; 2018 Aug; 10(16):1877-1880. PubMed ID: 29921135
[No Abstract] [Full Text] [Related]
19. Nanomedicines Targeting the Tumor Microenvironment.
Tong R; Langer R
Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
[TBL] [Abstract][Full Text] [Related]
20. Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment.
Ganipineni LP; Danhier F; Préat V
J Control Release; 2018 Jul; 281():42-57. PubMed ID: 29753958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
